Agilus Diagnostics appoints Vijender Singh as Managing Director and CEO
Agilus Diagnostics appointed Vijender Singh as Managing Director and Chief Executive Officer on July 20, 2026, succeeding Dr. Anand K. Singh brings extensive experience from roles including Group CEO of Metropolis Healthcare and Chairman of Diagnum Healthcare. The leadership change is intended to drive operational excellence and strengthen the company's market position.
*this image is generated using AI for illustrative purposes only.
Agilus Diagnostics appointed Vijender Singh as its Managing Director and Chief Executive Officer on July 20, 2026, effective immediately. The leadership change follows the resignation of Dr. Anand K, who served the company for nearly six years. The appointment aims to strengthen the company's position as a leading diagnostic service provider in India.
Leadership Appointment Details
The appointment was announced via a press release from Fortis Healthcare Limited, the parent company. The table below outlines the key details of the executive transition:
| Parameter | Details |
|---|---|
| Appointee | Vijender Singh |
| Designation | Managing Director & Chief Executive Officer |
| Organisation | Agilus Diagnostics |
| Effective Date | July 20, 2026 |
| Predecessor | Dr. Anand K |
Executive Background and Experience
Vijender Singh brings over three decades of leadership experience across diagnostics, healthcare, consumer healthcare, and FMCG sectors. Prior to this role, he served as the Chairman and Managing Director of Diagnum Healthcare. His previous leadership positions include Group CEO of Metropolis Healthcare and CEO of Healthians. He also spent nearly a decade with Dr. Lal PathLabs, contributing to its successful IPO journey and retail-focused diagnostics model.
Strategic Outlook
Dr. Ashutosh Raghuvanshi, Managing Director & Chief Executive Officer of Fortis Healthcare Limited and Chairman of Agilus Diagnostics, stated that Singh's expertise in business transformation and customer-centric growth will accelerate innovation and enhance the customer experience. Singh expressed his commitment to expanding access to high-quality diagnostics and creating long-term value for stakeholders.
What specific strategic initiatives will Vijender Singh prioritize to accelerate Agilus Diagnostics' growth in the competitive Indian market?
How might Singh's extensive experience with IPOs influence Agilus Diagnostics' potential future listing plans?
Will the new leadership trigger a shift in Agilus Diagnostics' merger and acquisition strategy to expand market share?
15
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
